Michel SidibŽ, leading HIV advocate, receives honorary doctorate of science from UBC

Michel SidibŽ, executive director of the Joint United Nations Programme on HIV/AIDS (UNAIDS) and pioneer in HIV prevention and treatment throughout the world, recently received an honorary doctorate of science from UBC.

Currently the executive director of UNAIDS, SidibŽ has spent over 30 years fighting for health, education and human rights across the world. As part of his lifelong commitment to public service, SidibŽ has also spent 14 years working for UNICEF, where he served as representative for several African countries.

At a graduation ceremony that happened to coincide with SidibŽ’s birthday on May 28, UBC recognized SidibŽ for his exceptional work in HIV prevention and treatment around the world.

Invited to take the podium, SidibŽ took this time to thank and impart inspirational words to the graduating class before him.

Gabby Plonka
The Ubyssey
Read The Full Story

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search